KIT and ovarian cancer: In ovarian cancer cells, BMP2 promotes cell proliferation and self-renewal capacity via c-Kit induction as well as cell migration and invasion via EMT [52]; these effects are TNFRSF12A/FN14-dependent, as silencing of FN14 suppresses BMP2 actions in ovarian cancer cells [53].